Lipid Metabolism Disorder
1
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
MSDIreland - Ballydine
1 programLipid Management in Clinical Practice (MK-0524A-115)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Luye PharmaXueZhiKang
MSDLipid Management in Clinical Practice (MK-0524A-115)
Clinical Trials (2)
Total enrollment: 2,410 patients across 2 trials
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
Start: Nov 2015Est. completion: Feb 201620 patients
Phase 1Completed
Lipid Management in Clinical Practice (MK-0524A-115)
Start: Oct 2009Est. completion: Feb 20112,390 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.